Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC)

Journal of Medicinal Chemistry

Volumn 57, Issue 9, 2014, Pages 3651-3665

  Chen, Haijun ^a,b   Wild, Christopher ^a   Zhou, Xiaobin ^b   Ye, Na ^a   Cheng, Xiaodong ^a   Zhou, Jia ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b FUZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPORTER; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE;

BIOLOGICAL FUNCTIONS; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW;

CRYSTALLOGRAPHY, X-RAY; DRUG DISCOVERY; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MODELS, MOLECULAR; SIGNAL TRANSDUCTION; SMALL MOLECULE LIBRARIES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84900319333     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm401425e     Document Type: Review

References (147)

1. Beavo, J. A.; Brunton, L. L. Cyclic nucleotide research - still expanding after half a century Nat. Rev. Mol. Cell Biol. 2002, 3, 710-718
2. Hanoune, J.; Defer, N. Regulation and role of adenylyl cyclase isoforms Annu. Rev. Pharmacol. Toxicol. 2001, 41, 145-174
3. Lugnier, C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents Pharmacol. Ther. 2006, 109, 366-398
4. Conti, M.; Beavo, J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling Annu. Rev. Biochem. 2007, 76, 481-511
5. Patel, H. H.; Murray, F.; Insel, P. A. G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains Handb. Exp. Pharmacol. 2008, 186, 167-184
6. Patel, H. H.; Murray, F.; Insel, P. A. Caveolae as organizers of pharmacologically relevant signal transduction molecules Annu. Rev. Pharmacol. Toxicol. 2008, 48, 359-391
7. Keravis, T.; Lugnier, C. Cyclic nucleotide phosphodiesterases (PDE) and peptide motifs Curr. Pharm. Des. 2010, 16, 1114-1125
8. Cohen, P. Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discovery 2002, 1, 309-315
9. Zambon, A. C.; Zhang, L.; Minovitsky, S.; Kanter, J. R.; Prabhakar, S.; Salomonis, N.; Vranizan, K.; Dubchak, I.; Conklin, B. R.; Insel, P. A. Gene expression patterns define key transcriptional events in cell-cycle regulation by cAMP and protein kinase A Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 8561-8566
10. Biel, M. Cyclic nucleotide-regulated cation channels J. Biol. Chem. 2009, 284, 9017-9021
11. Biel, M.; Michalakis, S. Cyclic nucleotide-gated channels Handb. Exp. Pharmacol. 2009, 191, 111-136
12. de Rooij, J.; Zwartkruis, F. J.; Verheijen, M. H.; Cool, R. H.; Nijman, S. M.; Wittinghofer, A.; Bos, J. L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP Nature 1998, 396, 474-477
13. Kawasaki, H.; Springett, G. M.; Mochizuki, N.; Toki, S.; Nakaya, M.; Matsuda, M.; Housman, D. E.; Graybiel, A. M. A family of cAMP-binding proteins that directly activate Rap1 Science 1998, 282, 2275-2279
14. de Rooij, J.; Rehmann, H.; van Triest, M.; Cool, R. H.; Wittinghofer, A.; Bos, J. L. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs J. Biol. Chem. 2000, 275, 20829-20836
15. Rehmann, H.; Arias-Palomo, E.; Hadders, M. A.; Schwede, F.; Llorca, O.; Bos, J. L. Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B Nature 2008, 455, 124-127
16. Rehmann, H.; Das, J.; Knipscheer, P.; Wittinghofer, A.; Bos, J. L. Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state Nature 2006, 439, 625-628
17. Rehmann, H.; Prakash, B.; Wolf, E.; Rueppel, A.; de Rooij, J.; Bos, J. L.; Wittinghofer, A. Structure and regulation of the cAMP-binding domains of Epac2 Nat. Struct. Biol. 2003, 10, 26-32
18. Rehmann, H.; Rueppel, A.; Bos, J. L.; Wittinghofer, A. Communication between the regulatory and the catalytic region of the cAMP-responsive guanine nucleotide exchange factor Epac J. Biol. Chem. 2003, 278, 23508-23514
19. Bos, J. L. Epac: a new cAMP target and new avenues in cAMP research Nat. Rev. Mol. Cell Biol. 2003, 4, 733-738
20. Bos, J. L. Epac proteins: multi-purpose cAMP targets Trends Biochem. Sci. 2006, 31, 680-686
21. Kilpinen, S.; Autio, R.; Ojala, K.; Iljin, K.; Bucher, E.; Sara, H.; Pisto, T.; Saarela, M.; Skotheim, R. I.; Bjorkman, M.; Mpindi, J. P.; Haapa-Paananen, S.; Vainio, P.; Edgren, H.; Wolf, M.; Astola, J.; Nees, M.; Hautaniemi, S.; Kallioniemi, O. Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues Genome Biol. 2008, 9, R139
22. Ueno, H.; Shibasaki, T.; Iwanaga, T.; Takahashi, K.; Yokoyama, Y.; Liu, L. M.; Yokoi, N.; Ozaki, N.; Matsukura, S.; Yano, H.; Seino, S. Characterization of the gene EPAC2: structure, chromosomal localization, tissue expression, and identification of the liver-specific isoform Genomics 2001, 78, 91-98
23. Mazhab-Jafari, M. T.; Das, R.; Fotheringham, S. A.; SilDas, S.; Chowdhury, S.; Melacini, G. Understanding cAMP-dependent allostery by NMR spectroscopy: comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-bound states J. Am. Chem. Soc. 2007, 129, 14482-14492
24. Das, R.; Chowdhury, S.; Mazhab-Jafari, M. T.; Sildas, S.; Selvaratnam, R.; Melacini, G. Dynamically driven ligand selectivity in cyclic nucleotide binding domains J. Biol. Chem. 2009, 284, 23682-23696
25. Harper, S. M.; Wienk, H.; Wechselberger, R. W.; Bos, J. L.; Boelens, R.; Rehmann, H. Structural dynamics in the activation of Epac J. Biol. Chem. 2008, 283, 6501-6508
26. Selvaratnam, R.; Chowdhury, S.; VanSchouwen, B.; Melacini, G. Mapping allostery through the covariance analysis of NMR chemical shifts Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 6133-6138
27. Selvaratnam, R.; VanSchouwen, B.; Fogolari, F.; Mazhab-Jafari, M. T.; Das, R.; Melacini, G. The projection analysis of NMR chemical shifts reveals extended EPAC autoinhibition determinants Biophys. J. 2012, 102, 630-639
28. DiPilato, L. M.; Cheng, X.; Zhang, J. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 16513-16518
29. Yu, S.; Fan, F.; Flores, S. C.; Mei, F.; Cheng, X. Dissecting the mechanism of Epac activation via hydrogen-deuterium exchange FT-IR and structural modeling Biochemistry 2006, 45, 15318-15326
30. Brock, M.; Fan, F.; Mei, F. C.; Li, S.; Gessner, C.; Woods, V. L., Jr.; Cheng, X. Conformational analysis of Epac activation using amide hydrogen/deuterium exchange mass spectrometry J. Biol. Chem. 2007, 282, 32256-32263
31. Tsalkova, T.; Blumenthal, D. K.; Mei, F. C.; White, M. A.; Cheng, X. Mechanism of Epac activation: structural and functional analyses of Epac2 hinge mutants with constitutive and reduced activities J. Biol. Chem. 2009, 284, 23644-23651
32. Li, S.; Tsalkova, T.; White, M. A.; Mei, F. C.; Liu, T.; Wang, D.; Woods, V. L., Jr.; Cheng, X. Mechanism of intracellular cAMP sensor Epac2 activation: cAMP-induced conformational changes identified by amide hydrogen/deuterium exchange mass spectrometry (DXMS) J. Biol. Chem. 2011, 286, 17889-17897
33. Bos, J. L. Linking Rap to cell adhesion Curr. Opin. Cell Biol. 2005, 17, 123-128
34. Roscioni, S. S.; Elzinga, C. R.; Schmidt, M. Epac: effectors and biological functions Naunyn Schmiedebergs Arch. Pharmacol. 2008, 377, 345-357
35. Schmidt, M.; Dekker, F. J.; Maarsingh, H. Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions Pharmacol. Rev. 2013, 65, 670-709
36. Rockman, H. A.; Koch, W. J.; Lefkowitz, R. J. Seven-transmembrane- spanning receptors and heart function Nature 2002, 415, 206-212
37. Bers, D. M. Calcium cycling and signaling in cardiac myocytes Annu. Rev. Physiol. 2008, 70, 23-49
38. Lohse, M. J.; Engelhardt, S.; Eschenhagen, T. What is the role of beta-adrenergic signaling in heart failure? Circ. Res. 2003, 93, 896-906
39. Schmidt, M.; Sand, C.; Jakobs, K. H.; Michel, M. C.; Weernink, P. A. Epac and the cardiovascular system Curr. Opin. Pharmacol. 2007, 7, 193-200
40. Laurent, A. C.; Breckler, M.; Berthouze, M.; Lezoualch, F. Role of Epac in brain and heart Biochem. Soc. Trans. 2012, 40, 51-57
41. Lee, L. C.; Maurice, D. H.; Baillie, G. S. Targeting protein-protein interactions within the cyclic AMP signaling system as a therapeutic strategy for cardiovascular disease Future Med. Chem. 2013, 5, 451-464
42. Ruiz-Hurtado, G.; Morel, E.; Dominguez-Rodriguez, A.; Llach, A.; Lezoualch, F.; Benitah, J. P.; Gomez, A. M. Epac in cardiac calcium signaling J. Mol. Cell Cardiol. 2013, 58, 162-171
43. El-Armouche, A.; Eschenhagen, T. Beta-adrenergic stimulation and myocardial function in the failing heart Heart Failure Rev. 2009, 14, 225-241
44. Morel, E.; Marcantoni, A.; Gastineau, M.; Birkedal, R.; Rochais, F.; Garnier, A.; Lompre, A. M.; Vandecasteele, G.; Lezoualch, F. cAMP-binding protein Epac induces cardiomyocyte hypertrophy Circ. Res. 2005, 97, 1296-1304
45. Somekawa, S.; Fukuhara, S.; Nakaoka, Y.; Fujita, H.; Saito, Y.; Mochizuki, N. Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes Circ. Res. 2005, 97, 655-662
46. 2+/calmodulin kinase signalling pathway in rat cardiac myocytes J. Physiol. 2007, 583, 685-694
47. Ulucan, C.; Wang, X.; Baljinnyam, E.; Bai, Y.; Okumura, S.; Sato, M.; Minamisawa, S.; Hirotani, S.; Ishikawa, Y. Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy Am. J. Physiol.: Heart Circ. Physiol. 2007, 293, H1662-1672
48. Metrich, M.; Lucas, A.; Gastineau, M.; Samuel, J. L.; Heymes, C.; Morel, E.; Lezoualch, F. Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy Circ. Res. 2008, 102, 959-965
49. 2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II J. Biol. Chem. 2009, 284, 1514-1522
50. 2+ leak and arrhythmia Circulation 2013, 127, 913-922
51. Leech, C. A.; Holz, G. G.; Chepurny, O.; Habener, J. F. Expression of cAMP-regulated guanine nucleotide exchange factors in pancreatic beta-cells Biochem. Biophys. Res. Commun. 2000, 278, 44-47
52. Gloerich, M.; Bos, J. L. Epac: defining a new mechanism for cAMP action Annu. Rev. Pharmacol. Toxicol. 2010, 50, 355-375
53. Zhang, C. L.; Katoh, M.; Shibasaki, T.; Minami, K.; Sunaga, Y.; Takahashi, H.; Yokoi, N.; Iwasaki, M.; Miki, T.; Seino, S. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs Science 2009, 325, 607-610
54. Herbst, K. J.; Coltharp, C.; Amzel, L. M.; Zhang, J. Direct activation of Epac by sulfonylurea is isoform selective Chem. Biol. 2011, 18, 243-251
55. Tsalkova, T.; Gribenko, A. V.; Cheng, X. Exchange protein directly activated by cyclic AMP isoform 2 is not a direct target of sulfonylurea drugs Assay Drug Dev. Technol. 2011, 9, 88-91
56. Parnell, E.; Smith, B. O.; Palmer, T. M.; Terrin, A.; Zaccolo, M.; Yarwood, S. J. Regulation of the inflammatory response of vascular endothelial cells by EPAC1 Br. J. Pharmacol. 2012, 166, 434-446
57. Rehmann, H. Epac2: a sulfonylurea receptor? Biochem. Soc. Trans. 2012, 40, 6-10
58. Park, J. H.; Kim, S. J.; Park, S. H.; Son, D. G.; Bae, J. H.; Kim, H. K.; Han, J.; Song, D. K. Glucagon-like peptide-1 enhances glucokinase activity in pancreatic beta-cells through the association of Epac2 with Rim2 and Rab3A Endocrinology 2012, 153, 574-582
59. Almahariq, M.; Mei, F. C.; Cheng, X. Cyclic AMP sensor EPAC proteins and energy homeostasis. Trends Endocrinol. Metab. [Online early access]. DOI: 10.1016/j.tem.2013.10.004. Published Online: Nov 12, 2013.
60. Ozaki, N.; Shibasaki, T.; Kashima, Y.; Miki, T.; Takahashi, K.; Ueno, H.; Sunaga, Y.; Yano, H.; Matsuura, Y.; Iwanaga, T.; Takai, Y.; Seino, S. cAMP-GEFII is a direct target of cAMP in regulated exocytosis Nat. Cell Biol. 2000, 2, 805-811
61. Wang, X.; Wang, Z. H.; Wu, Y. Y.; Tang, H.; Tan, L.; Wang, X.; Gao, X. Y.; Xiong, Y. S.; Liu, D.; Wang, J. Z.; Zhu, L. Q. Melatonin attenuates scopolamine-induced memory/synaptic disorder by rescuing EPACs/miR-124/Egr1 pathway Mol. Neurobiol. 2013, 47, 373-381
62. Yang, Y.; Shu, X.; Liu, D.; Shang, Y.; Wu, Y.; Pei, L.; Xu, X.; Tian, Q.; Zhang, J.; Qian, K.; Wang, Y. X.; Petralia, R. S.; Tu, W.; Zhu, L. Q.; Wang, J. Z.; Lu, Y. EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation Neuron 2012, 73, 774-788
63. Srivastava, D. P.; Jones, K. A.; Woolfrey, K. M.; Burgdorf, J.; Russell, T. A.; Kalmbach, A.; Lee, H.; Yang, C.; Bradberry, M. M.; Wokosin, D.; Moskal, J. R.; Casanova, M. F.; Waters, J.; Penzes, P. Social, communication, and cortical structural impairments in Epac2-deficient mice J. Neurosci. 2012, 32, 11864-11878
64. Christensen, A. E.; Selheim, F.; de Rooij, J.; Dremier, S.; Schwede, F.; Dao, K. K.; Martinez, A.; Maenhaut, C.; Bos, J. L.; Genieser, H. G.; Doskeland, S. O. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension J. Biol. Chem. 2003, 278, 35394-35402
65. McPhee, I.; Gibson, L. C.; Kewney, J.; Darroch, C.; Stevens, P. A.; Spinks, D.; Cooreman, A.; MacKenzie, S. J. Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimers disease Biochem. Soc. Trans. 2005, 33, 1330-1332
66. Gekel, I.; Neher, E. Application of an Epac activator enhances neurotransmitter release at excitatory central synapses J. Neurosci. 2008, 28, 7991-8002
67. Nijholt, I. M.; Dolga, A. M.; Ostroveanu, A.; Luiten, P. G.; Schmidt, M.; Eisel, U. L. Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation Cell. Signalling 2008, 20, 1715-1724
68. Ouyang, M.; Zhang, L.; Zhu, J. J.; Schwede, F.; Thomas, S. A. Epac signaling is required for hippocampus-dependent memory retrieval Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 11993-11997
69. Kelly, M. P.; Stein, J. M.; Vecsey, C. G.; Favilla, C.; Yang, X.; Bizily, S. F.; Esposito, M. F.; Wand, G.; Kanes, S. J.; Abel, T. Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia Mol. Psychiatry 2009, 14, 398-415
70. Ster, J.; de Bock, F.; Bertaso, F.; Abitbol, K.; Daniel, H.; Bockaert, J.; Fagni, L. Epac mediates PACAP-dependent long-term depression in the hippocampus J. Physiol. 2009, 587, 101-113
71. Dao, K. K.; Teigen, K.; Kopperud, R.; Hodneland, E.; Schwede, F.; Christensen, A. E.; Martinez, A.; Doskeland, S. O. Epac1 and cAMP-dependent protein kinase holoenzyme have similar cAMP affinity, but their cAMP domains have distinct structural features and cyclic nucleotide recognition J. Biol. Chem. 2006, 281, 21500-21511
72. Middeldorp, C. M.; Vink, J. M.; Hettema, J. M.; de Geus, E. J.; Kendler, K. S.; Willemsen, G.; Neale, M. C.; Boomsma, D. I.; Chen, X. An association between Epac-1 gene variants and anxiety and depression in two independent samples Am. J. Med. Genet., Part B 2010, 153B, 214-219
73. Srivastava, D. P.; Woolfrey, K. M.; Jones, K. A.; Anderson, C. T.; Smith, K. R.; Russell, T. A.; Lee, H.; Yasvoina, M. V.; Wokosin, D. L.; Ozdinler, P. H.; Shepherd, G. M.; Penzes, P. An autism-associated variant of Epac2 reveals a role for Ras/Epac2 signaling in controlling basal dendrite maintenance in mice PLoS Biol. 2012, 10, e1001350
74. Dudek, S. M.; Garcia, J. G. Cytoskeletal regulation of pulmonary vascular permeability J. Appl. Physiol. 2001, 91, 1487-1500
75. Cullere, X.; Shaw, S. K.; Andersson, L.; Hirahashi, J.; Luscinskas, F. W.; Mayadas, T. N. Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase Blood 2005, 105, 1950-1955
76. Mehta, D.; Malik, A. B. Signaling mechanisms regulating endothelial permeability Physiol. Rev. 2006, 86, 279-367
77. Fukuhara, S.; Sakurai, A.; Sano, H.; Yamagishi, A.; Somekawa, S.; Takakura, N.; Saito, Y.; Kangawa, K.; Mochizuki, N. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway Mol. Cell. Biol. 2005, 25, 136-146
78. Wittchen, E. S.; Worthylake, R. A.; Kelly, P.; Casey, P. J.; Quilliam, L. A.; Burridge, K. Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function J. Biol. Chem. 2005, 280, 11675-11682
79. Sands, W. A.; Woolson, H. D.; Milne, G. R.; Rutherford, C.; Palmer, T. M. Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells Mol. Cell. Biol. 2006, 26, 6333-6346
80. Netherton, S. J.; Sutton, J. A.; Wilson, L. S.; Carter, R. L.; Maurice, D. H. Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells Circ. Res. 2007, 101, 768-776
81. Schiermeier, Q. Westernizing Eastern-bloc science Nat. Biotechnol. 2008, 26, 949-950
82. Dejana, E.; Orsenigo, F.; Lampugnani, M. G. The role of adherens junctions and VE-cadherin in the control of vascular permeability J. Cell Sci. 2008, 121, 2115-2122
83. Borland, G.; Smith, B. O.; Yarwood, S. J. EPAC proteins transduce diverse cellular actions of cAMP Br. J. Pharmacol. 2009, 158, 70-86
84. Metrich, M.; Berthouze, M.; Morel, E.; Crozatier, B.; Gomez, A. M.; Lezoualch, F. Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology Pfluegers Arch. 2010, 459, 535-546
85. Sayner, S. L. Emerging themes of cAMP regulation of the pulmonary endothelial barrier Am. J. Physiol.: Lung Cell. Mol. Physiol. 2011, 300, L667-678
86. Eid, A. H. cAMP induces adhesion of microvascular smooth muscle cells to fibronectin via an Epac-mediated but PKA-independent mechanism Cell. Physiol. Biochem. 2012, 30, 247-258
87. Lorenowicz, M. J.; Fernandez-Borja, M.; Kooistra, M. R.; Bos, J. L.; Hordijk, P. L. PKA and Epac1 regulate endothelial integrity and migration through parallel and independent pathways Eur. J. Cell Biol. 2008, 87, 779-792
88. Adamson, R. H.; Ly, J. C.; Sarai, R. K.; Lenz, J. F.; Altangerel, A.; Drenckhahn, D.; Curry, F. E. Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery Am. J. Physiol.: Heart Circ. Physiol. 2008, 294, H1188-1196
89. Yokoyama, U.; Minamisawa, S.; Quan, H.; Akaike, T.; Jin, M.; Otsu, K.; Ulucan, C.; Wang, X.; Baljinnyam, E.; Takaoka, M.; Sata, M.; Ishikawa, Y. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration Am. J. Physiol.: Heart Circ. Physiol. 2008, 295, H1547-1555
90. Grandoch, M.; Roscioni, S. S.; Schmidt, M. The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function Br. J. Pharmacol. 2010, 159, 265-284
91. Jiang, J.; Dingledine, R. Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection Trends Pharmacol. Sci. 2013, 34, 413-423
92. Hata, A. N.; Breyer, R. M. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation Pharmacol. Ther. 2004, 103, 147-166
93. Lorenowicz, M. J.; van Gils, J.; de Boer, M.; Hordijk, P. L.; Fernandez-Borja, M. Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis J. Leukocyte Biol. 2006, 80, 1542-1552
94. Bryn, T.; Mahic, M.; Enserink, J. M.; Schwede, F.; Aandahl, E. M.; Tasken, K. The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages J. Immunol. 2006, 176, 7361-7370
95. Wang, H.; Heijnen, C. J.; van Velthoven, C. T. J.; Willemen, H. L. D. M.; Ishikawa, Y.; Zhang, X.; Sood, A. K.; Vroon, A.; Eijkelkamp, N.; Kavelaars, A. Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain. J. Clin. Invest. [Online early access]. DOI: 10.1172/JCI66241. Published Online: Nov 15, 2013.
96. Li, Y.; Konings, I. B.; Zhao, J.; Price, L. S.; de Heer, E.; Deen, P. M. Renal expression of exchange protein directly activated by cAMP (EPAC) 1 and 2 Am. J. Physiol.: Renal Physiol. 2008, 295, F525-533
97. Laroche-Joubert, N.; Marsy, S.; Michelet, S.; Imbert-Teboul, M.; Doucet, A. Protein kinase A-independent activation of ERK and H,K-ATPase by cAMP in native kidney cells: role of Epac I J. Biol. Chem. 2002, 277, 18598-18604
98. Yip, K. P. Epac-mediated Ca(2+) mobilization and exocytosis in inner medullary collecting duct Am. J. Physiol.: Renal Physiol. 2006, 291, F882-890
99. Helms, M. N.; Chen, X. J.; Ramosevac, S.; Eaton, D. C.; Jain, L. Dopamine regulation of amiloride-sensitive sodium channels in lung cells Am. J. Physiol.: Lung Cell. Mol. Physiol. 2006, 290, L710-L722
100. - channels in rat hepatocytes J. Physiol. 2006, 573, 611-625
101. Yang, S. K.; Xiao, L.; Li, J.; Liu, F.; Sun, L.; Kanwar, Y. S. Role of guanine-nucleotide exchange factor Epac in renal physiology and pathophysiology Am. J. Physiol.: Renal Physiol. 2013, 304, F831-839
102. Billington, C. K.; Hall, I. P. Novel cAMP signalling paradigms: therapeutic implications for airway disease Br. J. Pharmacol. 2012, 166, 401-410
103. Billington, C. K.; Ojo, O. O.; Penn, R. B.; Ito, S. cAMP regulation of airway smooth muscle function Pulm. Pharmacol. Ther. 2013, 26, 112-120
104. Dekkers, B. G.; Racke, K.; Schmidt, M. Distinct PKA and Epac compartmentalization in airway function and plasticity Pharmacol. Ther. 2013, 137, 248-265
105. Holz, G. G.; Kang, G.; Harbeck, M.; Roe, M. W.; Chepurny, O. G. Cell physiology of cAMP sensor Epac J. Physiol. 2006, 577, 5-15
106. Holz, G. G.; Chepurny, O. G.; Schwede, F. Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors Cell. Signalling 2008, 20, 10-20
107. Beavo, J. A.; Brunton, L. L. Cyclic nucleotide research - still expanding after half a century Nat. Rev. Mol. Cell Biol. 2002, 3, 710-718
108. Zhong, N.; Zucker, R. S. cAMP acts on exchange protein activated by cAMP/cAMP-regulated guanine nucleotide exchange protein to regulate transmitter release at the crayfish neuromuscular junction J. Neurosci. 2005, 25, 208-214
109. Bala, S.; Pathak, R. K.; Mishra, V. Identification of EPAC (exchange protein activated by cAMP) bioinformatically as a potential signalling biomarker in cardiovascular disease (CVD) and its molecular docking by a lead molecule Bioinformation 2011, 6, 176-178
110. Tsalkova, T.; Mei, F. C.; Cheng, X. A fluorescence-based high-throughput assay for the discovery of exchange protein directly activated by cyclic AMP (EPAC) antagonists PLoS One 2012, 7, e30441
111. Tsalkova, T.; Mei, F. C.; Li, S.; Chepurny, O. G.; Leech, C. A.; Liu, T.; Holz, G. G.; Woods, V. L., Jr.; Cheng, X. Isoform-specific antagonists of exchange proteins directly activated by cAMP Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 18613-18618
112. Almahariq, M.; Tsalkova, T.; Mei, F. C.; Chen, H.; Zhou, J.; Sastry, S. K.; Schwede, F.; Cheng, X. A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion Mol. Pharmacol. 2013, 83, 122-128
113. Courilleau, D.; Bisserier, M.; Jullian, J. C.; Lucas, A.; Bouyssou, P.; Fischmeister, R.; Blondeau, J. P.; Lezoualch, F. Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac J. Biol. Chem. 2012, 287, 44192-44202
114. Chen, H.; Tsalkova, T.; Mei, F. C.; Hu, Y.; Cheng, X.; Zhou, J. 5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP Bioorg. Med. Chem. Lett. 2012, 22, 4038-4043
115. Chen, H.; Tsalkova, T.; Chepurny, O. G.; Mei, F. C.; Holz, G. G.; Cheng, X.; Zhou, J. Identification and characterization of small molecules as potent and specific EPAC2 antagonists J. Med. Chem. 2013, 56, 952-962
116. Chen, H.; Ding, C.; Wild, C.; Liu, H.; Wang, T.; White, M. A.; Cheng, X.; Zhou, J. Efficient synthesis of ESI-09, a novel non-cyclic nucleotide EPAC antagonist Tetrahedron Lett. 2013, 54, 1546-1549
117. Jastorff, B.; Hoppe, J.; Morr, M. A model for the chemical interactions of adenosine 3′:5′-monophosphate with the R subunit of protein kinase type I. Refinement of the cyclic phosphate binding moiety of protein kinase type I Eur. J. Biochem. 1979, 101, 555-561
118. Szentandrassy, N.; Harmati, G.; Farkas, V.; Horvath, B.; Hegyi, B.; Magyar, J.; Szenasi, G.; Marton, I.; Nanasi, P. P. Modified cAMP derivatives: powerful tools in heart research Curr. Med. Chem. 2011, 18, 3729-3736
119. Van Haastert, P. J.; Van Driel, R.; Jastorff, B.; Baraniak, J.; Stec, W. J.; De Wit, R. J. Competitive cAMP antagonists for cAMP-receptor proteins J. Biol. Chem. 1984, 259, 10020-10024
120. de Wit, R. J.; Hekstra, D.; Jastorff, B.; Stec, W. J.; Baraniak, J.; Van Driel, R.; Van Haastert, P. J. Inhibitory action of certain cyclophosphate derivatives of cAMP on cAMP-dependent protein kinases Eur. J. Biochem. 1984, 142, 255-260
121. Botelho, L. H.; Rothermel, J. D.; Coombs, R. V.; Jastorff, B. cAMP analog antagonists of cAMP action Methods Enzymol. 1988, 159, 159-172
122. Rehmann, H.; Schwede, F.; Doskeland, S. O.; Wittinghofer, A.; Bos, J. L. Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac J. Biol. Chem. 2003, 278, 38548-38556
123. Bertinetti, D.; Schweinsberg, S.; Hanke, S. E.; Schwede, F.; Bertinetti, O.; Drewianka, S.; Genieser, H. G.; Herberg, F. W. Chemical tools selectively target components of the PKA system BMC Chem. Biol. 2009, 9, 3
124. de Wit, R. J.; Hoppe, J.; Stec, W. J.; Baraniak, J.; Jastorff, B. Interaction of cAMP derivatives with the "stable" cAMP-binding site in the cAMP-dependent protein kinase type I Eur. J. Biochem. 1982, 122, 95-99
125. OBrian, C. A.; Roczniak, S. O.; Bramson, H. N.; Baraniak, J.; Stec, W. J.; Kaiser, E. T. A kinetic study of interactions of (Rp)- and (Sp)-adenosine cyclic 3′,5′-phosphorothioates with type II bovine cardiac muscle adenosine cyclic 3′,5′-phosphate dependent protein kinase Biochemistry 1982, 21, 4371-4376
126. Gjertsen, B. T.; Mellgren, G.; Otten, A.; Maronde, E.; Genieser, H. G.; Jastorff, B.; Vintermyr, O. K.; McKnight, G. S.; Doskeland, S. O. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action J. Biol. Chem. 1995, 270, 20599-20607
127. Su, Y.; Dostmann, W. R.; Herberg, F. W.; Durick, K.; Xuong, N. H.; Ten Eyck, L.; Taylor, S. S.; Varughese, K. I. Regulatory subunit of protein kinase A: structure of deletion mutant with cAMP binding domains Science 1995, 269, 807-813
128. Enserink, J. M.; Christensen, A. E.; de Rooij, J.; van Triest, M.; Schwede, F.; Genieser, H. G.; Doskeland, S. O.; Blank, J. L.; Bos, J. L. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK Nat. Cell Biol. 2002, 4, 901-906
129. Schwede, F.; Christensen, A.; Liauw, S.; Hippe, T.; Kopperud, R.; Jastorff, B.; Doskeland, S. O. 8-Substituted cAMP analogues reveal marked differences in adaptability, hydrogen bonding, and charge accommodation between homologous binding sites (AI/AII and BI/BII) in cAMP kinase I and II Biochemistry 2000, 39, 8803-8812
130. Bartsch, M.; Zorn-Kruppa, M.; Kuhl, N.; Genieser, H. G.; Schwede, F.; Jastorff, B. Bioactivatable, membrane-permeant analogs of cyclic nucleotides as biological tools for growth control of C6 glioma cells Biol. Chem. 2003, 384, 1321-1326
131. Ogreid, D.; Ekanger, R.; Suva, R. H.; Miller, J. P.; Sturm, P.; Corbin, J. D.; Doskeland, S. O. Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination. Principles for optimizing the isozyme specificity of analog combinations Eur. J. Biochem. 1985, 150, 219-227
132. Huseby, S.; Gausdal, G.; Keen, T. J.; Kjaerland, E.; Krakstad, C.; Myhren, L.; Bronstad, K.; Kunick, C.; Schwede, F.; Genieser, H. G.; Kleppe, R.; Doskeland, S. O. Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription Cell Death Dis. 2011, 2, e237
133. Hucho, T. B.; Dina, O. A.; Levine, J. D. Epac mediates a cAMP-to-PKC signaling in inflammatory pain: an isolectin B4(+) neuron-specific mechanism J. Neurosci. 2005, 25, 6119-6126
134. Stokman, G.; Qin, Y.; Genieser, H. G.; Schwede, F.; de Heer, E.; Bos, J. L.; Bajema, I. M.; van de Water, B.; Price, L. S. Epac-Rap signaling reduces cellular stress and ischemia-induced kidney failure J. Am. Soc. Nephrol. 2011, 22, 859-872
135. Ostroveanu, A.; van der Zee, E. A.; Eisel, U. L.; Schmidt, M.; Nijholt, I. M. Exchange protein activated by cyclic AMP 2 (Epac2) plays a specific and time-limited role in memory retrieval Hippocampus 2010, 20, 1018-1026
136. Vliem, M. J.; Ponsioen, B.; Schwede, F.; Pannekoek, W. J.; Riedl, J.; Kooistra, M. R.; Jalink, K.; Genieser, H. G.; Bos, J. L.; Rehmann, H. 8-pCPT-2′-O-Me-cAMP-AM: an improved Epac-selective cAMP analogue ChemBioChem 2008, 9, 2052-2054
137. Poppe, H.; Rybalkin, S. D.; Rehmann, H.; Hinds, T. R.; Tang, X. B.; Christensen, A. E.; Schwede, F.; Genieser, H. G.; Bos, J. L.; Doskeland, S. O.; Beavo, J. A.; Butt, E. Cyclic nucleotide analogs as probes of signaling pathways Nat. Methods 2008, 5, 277-278
138. Kraemer, A.; Rehmann, H. R.; Cool, R. H.; Theiss, C.; de Rooij, J.; Bos, J. L.; Wittinghofer, A. Dynamic interaction of cAMP with the Rap guanine-nucleotide exchange factor Epac1 J. Mol. Biol. 2001, 306, 1167-1177
139. Chen, H.; Yang, Z.; Ding, C.; Chu, L.; Zhang, Y.; Terry, K.; Liu, H.; Shen, Q.; Zhou, J. Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy Eur. J. Med. Chem. 2013, 62, 498-507
140. Chen, H.; Wang, C. Z.; Ding, C.; Wild, C.; Copits, B.; Swanson, G. T.; Johnson, K. M.; Zhou, J. A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as neuroprotective agents ChemMedChem 2013, 8, 226-230
141. Rehmann, H. Epac-inhibitors: facts and artefacts Sci. Rep. 2013, 3, 3032
142. Fukuda, M.; Williams, K. W.; Gautron, L.; Elmquist, J. K. Induction of leptin resistance by activation of cAMP-Epac signaling Cell Metab. 2011, 13, 331-339
143. Yan, J.; Mei, F. C.; Cheng, H.; Lao, D. H.; Hu, Y.; Wei, J.; Patrikeev, I.; Hao, D.; Stutz, S. J.; Dineley, K. T.; Motamedi, M.; Hommel, J. D.; Cunningham, K. A.; Chen, J.; Cheng, X. Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1 Mol. Cell. Biol. 2013, 33, 918-926
144. Gong, B.; Shelite, T.; Mei, F.; Ha, T.; Hu, Y.; Xu, G.; Chang, Q.; Wakamiya, M.; Ksiazek, T. G.; Boor, P. J.; Bouyer, D.; Popov, V.; Chen, J.; Walker, D. H.; Cheng, X. Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses. Proc. Natl. Acad. Sci. U.S.A. [Online early access]. DOI: 10.1073/pnas.1314400110. Published Online: Nov 11, 2013.
145. van den Berghe, N.; Cool, R. H.; Horn, G.; Wittinghofer, A. Biochemical characterization of C3G: an exchange factor that discriminates between Rap1 and Rap2 and is not inhibited by Rap1A(S17N) Oncogene 1997, 15, 845-850
146. Courilleau, D.; Bouyssou, P.; Fischmeister, R.; Lezoualch, F.; Blondeau, J. P. The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (EPAC1) Biochem. Biophys. Res. Commun. 2013, 440, 443-448
147. Cheng, X.; Ji, Z.; Tsalkova, T.; Mei, F. Epac and PKA: a tale of two intracellular cAMP receptors Acta Biochim. Biophys. Sin. 2008, 40, 651-662